Qiang Ding - Concepedia

Author

Qiang Ding

Genomics Institute of the Novartis Research Foundation ORCID

Also Known As

Ding Q, Ding Qiang, Q. Ding, Qiang Ding, Xiaobo Zhang

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Genomics Institute of the Novartis Research Foundation Scripps Research Institute Novartis Institutes for BioMedical Research Novartis (Switzerland)Korea Institute of Science and Technology

About

Qiang Ding is an author at Genomics Institute of the Novartis Research Foundation specializing in medicine, cell biology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.6K
2	Engineering	5	5	307
3	Biochemistry	5	5	316
4	Natural Sciences	4	4	287
5	Health Sciences	2	2	108

Qiang Ding

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors Jianming Zhang, Francisco Adrián, Wolfgang Jahnke, Nature Molecular PharmacologyDrug TargetMedicineAtp-binding-site InhibitorsAnti-cancer Agent	2010	590
Allosteric inhibitors of Bcr-abl–dependent cell proliferation Francisco Adrián, Qiang Ding, Taebo Sim, Nature Chemical Biology Molecular PharmacologyMedicineAllosteric InhibitorsAnti-cancer AgentPharmacology	2006	376
Small Molecules that Induce Cardiomyogenesis in Embryonic Stem Cells Xu Wu, Sheng Ding, Qiang Ding, Journal of the American Chemical Society	2004	227
A Small Molecule with Osteogenesis-Inducing Activity in Multipotent Mesenchymal Progenitor Cells Xu Wu, Sheng Ding, Qiang Ding, Journal of the American Chemical Society Regenerative MedicineTissue EngineeringHeterocycle Combinatorial LibraryOsteogenesis-inducing ActivityDevelopmental Biology	2002	208
A Combinatorial Scaffold Approach toward Kinase-Directed Heterocycle Libraries Sheng Ding, Nathanael S. Gray, Xu Wu, Journal of the American Chemical Society Combinatorial ChemistryTargeted LibraryMedicinal ChemistryEngineeringHeterocyclic	2002	166
MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24 Yan Cao, Shiliang Yu, Yan Wang, Tumor Biology	2010	80
Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133 Yahu A. Liu, Qihui Jin, Yefen Zou, Journal of Medicinal Chemistry	2020	74
A Type-II Kinase Inhibitor Capable of Inhibiting the T315I “Gatekeeper” Mutant of Bcr-Abl Hwan Geun Choi, Pingda Ren, Francisco Adrián, Journal of Medicinal Chemistry -One ScaffoldCompound 2Tumor BiologyDrug ResistanceImatinib Resistance	2010	73
Expanding the diversity of purine libraries Sheng Ding, Nathanael S. Gray, Qiang Ding, Tetrahedron Letters BiologyTargeted LibraryMolecular DiversityDrug DiscoveryPurine Libraries	2001	68
Discovery of EGFR Selective 4,6-Disubstituted Pyrimidines from a Combinatorial Kinase-Directed Heterocycle Library Qiong Zhang, Yi Liu, Feng Gao, Journal of the American Chemical Society Combinatorial ChemistryFirst Receptor TyrosineTyrosine KinaseMolecular BiologyChemical Biology	2006	60

Page 1